Please assess the completion status of the following clinical trial:

Trial Title: HFNC vs LFNC in Patients With AF Undergoing RFCA Under Deep Sedation.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults undergoing an elective RFCA for atrial fibrillation in the Maastricht UMC Cardiac Catheter Labs under deep sedation administered by a clinician anesthesiology~Exclusion Criteria:~* Age under 18 years~* Body Mass Index (BMI) \> 32 kg/m²~* Diagnosed Sleep Apnoea Syndrome (SAS)~* Chronic Pulmonary Obstructive Disease (COPD) gold IV and COPD gold III with frequent or recent exacerbation~* Diagnosed pulmonary or cardiac condition requiring chronic oxygen therapy~* Complete nasal obstruction~* Active nose bleeding~* Untreated pneumothorax (pre- existing)~* Recent upper airway surgery~* Recent base of skull fracture~* Expected difficult airway

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- High flow nasal cannula (Type: EXPERIMENTAL): Participants in the high flow nasal cannula group will receive high flow nasal cannula oxygen during deep sedation.
- Low flow nasal cannula (Type: NO_INTERVENTION): Participants in the current standard of care will receive low flow nasal cannula during deep sedation.

Based on this trial design, predict the completion outcome and termination type (if applicable).